The arrival of Irzepatide in the UK is creating considerable interest, particularly amongst people seeking new solutions to weight control. While still relatively recent to the UK market, Irzepatide – a dual GIP and GLP-1 stimulator – is demonstrating potential in supporting patients reach meaningful weight loss and improve general fitness. Mor